These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 32270905)
21. Effect of raloxifene on the response to conjugated estrogen vaginal cream or nonhormonal moisturizers in postmenopausal vaginal atrophy. Parsons A; Merritt D; Rosen A; Heath H; Siddhanti S; Plouffe L; Obstet Gynecol; 2003 Feb; 101(2):346-52. PubMed ID: 12576260 [TBL] [Abstract][Full Text] [Related]
22. Efficacy and safety of vaginal estriol and progesterone in postmenopausal women with atrophic vaginitis. Chollet JA; Carter G; Meyn LA; Mermelstein F; Balk JL Menopause; 2009; 16(5):978-83. PubMed ID: 19390463 [TBL] [Abstract][Full Text] [Related]
23. A Randomized, Multicenter, Double-Blind, Study to Evaluate the Safety and Efficacy of Estradiol Vaginal Cream 0.003% in Postmenopausal Women with Vaginal Dryness as the Most Bothersome Symptom. Archer DF; Kimble TD; Lin FDY; Battucci S; Sniukiene V; Liu JH J Womens Health (Larchmt); 2018 Mar; 27(3):231-237. PubMed ID: 29193980 [TBL] [Abstract][Full Text] [Related]
24. Does vaginal estriol make urodynamic changes in women with overactive bladder syndrome and genitourinary syndrome of menopause? Matarazzo MG; Caruso S; Giunta G; Valenti G; Sarpietro G; Cianci A Eur J Obstet Gynecol Reprod Biol; 2018 Mar; 222():75-79. PubMed ID: 29367168 [TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetics and preliminary efficacy of two vaginal gel formulations of ultra-low-dose estriol in postmenopausal women. Delgado JL; Estevez J; Radicioni M; Loprete L; Moscoso Del Prado J; Nieto Magro C Climacteric; 2016 Apr; 19(2):172-80. PubMed ID: 26786399 [TBL] [Abstract][Full Text] [Related]
26. Low-dose, vaginally administered estrogens may enhance local benefits of systemic therapy in the treatment of urogenital atrophy in postmenopausal women on hormone therapy. Palacios S; Castelo-Branco C; Cancelo MJ; Vázquez F Maturitas; 2005 Feb; 50(2):98-104. PubMed ID: 15653006 [TBL] [Abstract][Full Text] [Related]
27. A randomized, multicenter, double-blind study to evaluate the safety and efficacy of estradiol vaginal cream 0.003% in postmenopausal women with dyspareunia as the most bothersome symptom. Kroll R; Archer DF; Lin Y; Sniukiene V; Liu JH Menopause; 2018 Feb; 25(2):133-138. PubMed ID: 28926514 [TBL] [Abstract][Full Text] [Related]
28. Benefits of vaginal estriol cream combined with clonidine HCL for menopausal syndrome treatment. Blum M Clin Exp Obstet Gynecol; 1985; 12(1-2):1-2. PubMed ID: 3987021 [TBL] [Abstract][Full Text] [Related]
29. Twice-weekly synthetic conjugated estrogens vaginal cream for the treatment of vaginal atrophy. Freedman M; Kaunitz AM; Reape KZ; Hait H; Shu H Menopause; 2009; 16(4):735-41. PubMed ID: 19252451 [TBL] [Abstract][Full Text] [Related]
30. Ovestin vaginal cream and suppositories for the treatment of menopausal vaginal atrophy. Trevoux R; van der Velden WH; Popović D Reproduccion; 1982; 6(2):101-6. PubMed ID: 7141096 [TBL] [Abstract][Full Text] [Related]
31. Effect of ultra-low-dose estriol and lactobacilli vaginal tablets (Gynoflor®) on inflammatory and infectious markers of the vaginal ecosystem in postmenopausal women with breast cancer on aromatase inhibitors. Donders G; Bellen G; Neven P; Grob P; Prasauskas V; Buchholz S; Ortmann O Eur J Clin Microbiol Infect Dis; 2015 Oct; 34(10):2023-8. PubMed ID: 26223323 [TBL] [Abstract][Full Text] [Related]
32. Comparison of Pueraria mirifica gel and conjugated equine estrogen cream effects on vaginal health in postmenopausal women. Suwanvesh N; Manonai J; Sophonsritsuk A; Cherdshewasart W Menopause; 2017 Feb; 24(2):210-215. PubMed ID: 27749740 [TBL] [Abstract][Full Text] [Related]
33. Effect of Foeniculum vulgare (fennel) vaginal cream on vaginal atrophy in postmenopausal women: A double-blind randomized placebo-controlled trial. Yaralizadeh M; Abedi P; Najar S; Namjoyan F; Saki A Maturitas; 2016 Feb; 84():75-80. PubMed ID: 26617271 [TBL] [Abstract][Full Text] [Related]
34. [Treatment of climacteric urogenital disorders with an estriol-containing ointment]. Koloszár S; Kovács L Orv Hetil; 1995 Feb; 136(7):343-5. PubMed ID: 7870416 [TBL] [Abstract][Full Text] [Related]
35. One-year treatment persistence with local estrogen therapy in postmenopausal women diagnosed as having vaginal atrophy. Portman D; Shulman L; Yeaw J; Zeng S; Uzoigwe C; Maamari R; Iyer NN Menopause; 2015 Nov; 22(11):1197-203. PubMed ID: 25944522 [TBL] [Abstract][Full Text] [Related]
36. Coital pain in the elderly: could a low dose estriol gel thrill the vulvar vestibule? Murina F; Graziottin A; Felice R; Di Francesco S Eur J Obstet Gynecol Reprod Biol; 2016 Dec; 207():121-124. PubMed ID: 27838536 [TBL] [Abstract][Full Text] [Related]
37. Effect of fennel vaginal cream on sexual function in postmenopausal women: A double blind randomized controlled trial. Abedi P; Najafian M; Yaralizadeh M; Namjoyan F J Med Life; 2018; 11(1):24-28. PubMed ID: 29696061 [No Abstract] [Full Text] [Related]
38. Higher than expected estradiol levels in aromatase inhibitor-treated, postmenopausal breast cancer patients. Kunovac Kallak T; Baumgart J; Stavreus Evers A; Sundström Poromaa I; Moby L; Kask K; Norjavaara E; Kushnir MM; Bergquist J; Nilsson K Climacteric; 2012 Oct; 15(5):473-80. PubMed ID: 22324859 [TBL] [Abstract][Full Text] [Related]
39. Topical estrogen protects against SIV vaginal transmission without evidence of systemic effect. Smith SM; Mefford M; Sodora D; Klase Z; Singh M; Alexander N; Hess D; Marx PA AIDS; 2004 Aug; 18(12):1637-43. PubMed ID: 15280774 [TBL] [Abstract][Full Text] [Related]
40. Effect of raloxifene on sexual function in postmenopausal women. Kessel B; Nachtigall L; Plouffe L; Siddhanti S; Rosen A; Parsons A Climacteric; 2003 Sep; 6(3):248-56. PubMed ID: 14567773 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]